Dr. Chinazom U. Ibegbu, MD

Dr. Ibegbu practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Ibegbu's NPI, 1720346125, was assigned on April 24, 2012. Dr. Ibegbu graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2012. Dr. Ibegbu holds New York license 284955.

Dr. Ibegbu's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Ibegbu's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Ibegbu is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Ibegbu to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibegbu practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ibegbu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ibegbu is licensed in New York.

CMS data shows 29 Medicare services from Dr. Ibegbu across 2 procedure codes in 2023, for 36 Medicare patients. Medicare paid $1,694 for them.

CMS counts 36 Medicare patients who saw Dr. Ibegbu in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ibegbu's median patient age at 63, with 48% women.

In 2024, Dr. Ibegbu wrote 297 Medicare Part D claims for 54 patients. 95% of them were for generic drugs. CMS names the drug for 133 of them, across 5 drugs with 11 or more claims each, at $3,918 in total drug cost. In 2023, CMS named 151 claims across 8 drugs.

Dr. Ibegbu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Ibegbu, published from 2018 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Feasibility Studies and Glioma. Dr. Ibegbu has published most often in Support Care Cancer. Dr. Ibegbu's most frequent co-authors are Nimish A. Mohile, MD, Ajay Prakash Abad, MD and Rachel Anne Kitt, MD.

CMS Open Payments shows 10 general payments to Dr. Ibegbu from 4 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 90% of the total. EMD Serono, Inc. paid the most, $461.

Dr. Ibegbu graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2012.